世界のイルベサルタンAPI市場インサイト・予測（～2027年）

• 英文タイトル：Global Irbesartan API Market Insights and Forecast to 2027

• レポートコード：QY2108PAL0243 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はイルベサルタンAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。イルベサルタンAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度≥98％、純度<98％）、用途別市場規模（イルベサルタン錠、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・イルベサルタンAPIの世界市場概要 ・メーカー別の競争状況、市場シェア ・イルベサルタンAPIの種類別市場規模：純度≥98％、純度<98％ ・イルベサルタンAPIの用途別市場規模：イルベサルタン錠、その他 ・北米のイルベサルタンAPI市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのイルベサルタンAPI市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのイルベサルタンAPI市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のイルベサルタンAPI市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのイルベサルタンAPI市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Dr. Reddy’s Laboratories Ltd.、Tecoland Corporation、Teva API、Divis Laboratories Ltd.、Rundu Pharma、Apeloa Pharmaceutical Co., Ltd.、CTX Lifesciences、Unichem Laboratories Limited、Zhejiang Huahai Pharmaceuticals Co., Ltd、Smilax Laboratories Limited ・イルベサルタンAPIのバリューチェーン・販売チャネル分析 ・イルベサルタンAPIの世界市場動向

Irbesartan is a nonpeptide angiotensin II antagonist with antihypertensive activity. Irbesartan selectively and competitively blocks the binding of angiotensin II to the angiotensin I receptor. Angiotensin II stimulates aldosterone synthesis and secretion by adrenal cortex, which decreases the excretion of sodium and increases the excretion of potassium. Angiotensin II also acts as a vasoconstrictor in vascular smooth muscle.

Market Analysis and Insights: Global Irbesartan API Market
The global Irbesartan API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Irbesartan API Scope and Segment
Irbesartan API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Irbesartan API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Purity≥98%
Purity<98% Segment by Application Irbesartan Tablets Others By Company Dr. Reddy’s Laboratories Ltd. Tecoland Corporation Teva API Divis Laboratories Ltd. Rundu Pharma Apeloa Pharmaceutical Co., Ltd. CTX Lifesciences Unichem Laboratories Limited Zhejiang Huahai Pharmaceuticals Co., Ltd Smilax Laboratories Limited Production by Region North America India China Israel Consumption by Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE

レポート目次

---

1 Study Coverage
1.1 Irbesartan API Product Introduction
1.2 Market by Type
1.2.1 Global Irbesartan API Market Size Growth Rate by Type
1.2.2 Purity≥98%
1.2.3 Purity<98% 1.3 Market by Application 1.3.1 Global Irbesartan API Market Size Growth Rate by Application 1.3.2 Irbesartan Tablets 1.3.3 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Irbesartan API Production 2.1 Global Irbesartan API Production Capacity (2016-2027) 2.2 Global Irbesartan API Production by Region: 2016 VS 2021 VS 2027 2.3 Global Irbesartan API Production by Region 2.3.1 Global Irbesartan API Historic Production by Region (2016-2021) 2.3.2 Global Irbesartan API Forecasted Production by Region (2022-2027) 2.4 North America 2.5 India 2.6 China 2.7 Israel 3 Global Irbesartan API Sales in Volume & Value Estimates and Forecasts 3.1 Global Irbesartan API Sales Estimates and Forecasts 2016-2027 3.2 Global Irbesartan API Revenue Estimates and Forecasts 2016-2027 3.3 Global Irbesartan API Revenue by Region: 2016 VS 2021 VS 2027 3.4 Global Top Irbesartan API Regions by Sales 3.4.1 Global Top Irbesartan API Regions by Sales (2016-2021) 3.4.2 Global Top Irbesartan API Regions by Sales (2022-2027) 3.5 Global Top Irbesartan API Regions by Revenue 3.5.1 Global Top Irbesartan API Regions by Revenue (2016-2021) 3.5.2 Global Top Irbesartan API Regions by Revenue (2022-2027) 3.6 North America 3.7 Europe 3.8 Asia-Pacific 3.9 Latin America 3.10 Middle East & Africa 4 Competition by Manufactures 4.1 Global Irbesartan API Production Capacity by Manufacturers 4.2 Global Irbesartan API Sales by Manufacturers 4.2.1 Global Top Irbesartan API Manufacturers by Sales (2016-2021) 4.2.2 Global Top Irbesartan API Manufacturers Market Share by Sales (2016-2021) 4.2.3 Global Top 10 and Top 5 Companies by Irbesartan API Sales in 2020 4.3 Global Irbesartan API Revenue by Manufacturers 4.3.1 Global Top Irbesartan API Manufacturers by Revenue (2016-2021) 4.3.2 Global Top Irbesartan API Manufacturers Market Share by Revenue (2016-2021) 4.3.3 Global Top 10 and Top 5 Companies by Irbesartan API Revenue in 2020 4.4 Global Irbesartan API Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global Irbesartan API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global Irbesartan API Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Market Size by Type 5.1 Global Irbesartan API Sales by Type 5.1.1 Global Irbesartan API Historical Sales by Type (2016-2021) 5.1.2 Global Irbesartan API Forecasted Sales by Type (2022-2027) 5.1.3 Global Irbesartan API Sales Market Share by Type (2016-2027) 5.2 Global Irbesartan API Revenue by Type 5.2.1 Global Irbesartan API Historical Revenue by Type (2016-2021) 5.2.2 Global Irbesartan API Forecasted Revenue by Type (2022-2027) 5.2.3 Global Irbesartan API Revenue Market Share by Type (2016-2027) 5.3 Global Irbesartan API Price by Type 5.3.1 Global Irbesartan API Price by Type (2016-2021) 5.3.2 Global Irbesartan API Price Forecast by Type (2022-2027) 6 Market Size by Application 6.1 Global Irbesartan API Sales by Application 6.1.1 Global Irbesartan API Historical Sales by Application (2016-2021) 6.1.2 Global Irbesartan API Forecasted Sales by Application (2022-2027) 6.1.3 Global Irbesartan API Sales Market Share by Application (2016-2027) 6.2 Global Irbesartan API Revenue by Application 6.2.1 Global Irbesartan API Historical Revenue by Application (2016-2021) 6.2.2 Global Irbesartan API Forecasted Revenue by Application (2022-2027) 6.2.3 Global Irbesartan API Revenue Market Share by Application (2016-2027) 6.3 Global Irbesartan API Price by Application 6.3.1 Global Irbesartan API Price by Application (2016-2021) 6.3.2 Global Irbesartan API Price Forecast by Application (2022-2027) 7 North America 7.1 North America Irbesartan API Market Size by Type 7.1.1 North America Irbesartan API Sales by Type (2016-2027) 7.1.2 North America Irbesartan API Revenue by Type (2016-2027) 7.2 North America Irbesartan API Market Size by Application 7.2.1 North America Irbesartan API Sales by Application (2016-2027) 7.2.2 North America Irbesartan API Revenue by Application (2016-2027) 7.3 North America Irbesartan API Sales by Country 7.3.1 North America Irbesartan API Sales by Country (2016-2027) 7.3.2 North America Irbesartan API Revenue by Country (2016-2027) 7.3.3 United States 7.3.4 Canada 8 Europe 8.1 Europe Irbesartan API Market Size by Type 8.1.1 Europe Irbesartan API Sales by Type (2016-2027) 8.1.2 Europe Irbesartan API Revenue by Type (2016-2027) 8.2 Europe Irbesartan API Market Size by Application 8.2.1 Europe Irbesartan API Sales by Application (2016-2027) 8.2.2 Europe Irbesartan API Revenue by Application (2016-2027) 8.3 Europe Irbesartan API Sales by Country 8.3.1 Europe Irbesartan API Sales by Country (2016-2027) 8.3.2 Europe Irbesartan API Revenue by Country (2016-2027) 8.3.3 Germany 8.3.4 France 8.3.5 U.K. 8.3.6 Italy 8.3.7 Russia 9 Asia Pacific 9.1 Asia Pacific Irbesartan API Market Size by Type 9.1.1 Asia Pacific Irbesartan API Sales by Type (2016-2027) 9.1.2 Asia Pacific Irbesartan API Revenue by Type (2016-2027) 9.2 Asia Pacific Irbesartan API Market Size by Application 9.2.1 Asia Pacific Irbesartan API Sales by Application (2016-2027) 9.2.2 Asia Pacific Irbesartan API Revenue by Application (2016-2027) 9.3 Asia Pacific Irbesartan API Sales by Region 9.3.1 Asia Pacific Irbesartan API Sales by Region (2016-2027) 9.3.2 Asia Pacific Irbesartan API Revenue by Region (2016-2027) 9.3.3 China 9.3.4 Japan 9.3.5 South Korea 9.3.6 India 9.3.7 Australia 9.3.8 China Taiwan 9.3.9 Indonesia 9.3.10 Thailand 9.3.11 Malaysia 10 Latin America 10.1 Latin America Irbesartan API Market Size by Type 10.1.1 Latin America Irbesartan API Sales by Type (2016-2027) 10.1.2 Latin America Irbesartan API Revenue by Type (2016-2027) 10.2 Latin America Irbesartan API Market Size by Application 10.2.1 Latin America Irbesartan API Sales by Application (2016-2027) 10.2.2 Latin America Irbesartan API Revenue by Application (2016-2027) 10.3 Latin America Irbesartan API Sales by Country 10.3.1 Latin America Irbesartan API Sales by Country (2016-2027) 10.3.2 Latin America Irbesartan API Revenue by Country (2016-2027) 10.3.3 Mexico 10.3.4 Brazil 10.3.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Irbesartan API Market Size by Type 11.1.1 Middle East and Africa Irbesartan API Sales by Type (2016-2027) 11.1.2 Middle East and Africa Irbesartan API Revenue by Type (2016-2027) 11.2 Middle East and Africa Irbesartan API Market Size by Application 11.2.1 Middle East and Africa Irbesartan API Sales by Application (2016-2027) 11.2.2 Middle East and Africa Irbesartan API Revenue by Application (2016-2027) 11.3 Middle East and Africa Irbesartan API Sales by Country 11.3.1 Middle East and Africa Irbesartan API Sales by Country (2016-2027) 11.3.2 Middle East and Africa Irbesartan API Revenue by Country (2016-2027) 11.3.3 Turkey 11.3.4 Saudi Arabia 11.3.5 UAE 12 Corporate Profiles 12.1 Dr. Reddy’s Laboratories Ltd. 12.1.1 Dr. Reddy’s Laboratories Ltd. Corporation Information 12.1.2 Dr. Reddy’s Laboratories Ltd. Overview 12.1.3 Dr. Reddy’s Laboratories Ltd. Irbesartan API Sales, Price, Revenue and Gross Margin (2016-2021) 12.1.4 Dr. Reddy’s Laboratories Ltd. Irbesartan API Product Description 12.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments 12.2 Tecoland Corporation 12.2.1 Tecoland Corporation Corporation Information 12.2.2 Tecoland Corporation Overview 12.2.3 Tecoland Corporation Irbesartan API Sales, Price, Revenue and Gross Margin (2016-2021) 12.2.4 Tecoland Corporation Irbesartan API Product Description 12.2.5 Tecoland Corporation Recent Developments 12.3 Teva API 12.3.1 Teva API Corporation Information 12.3.2 Teva API Overview 12.3.3 Teva API Irbesartan API Sales, Price, Revenue and Gross Margin (2016-2021) 12.3.4 Teva API Irbesartan API Product Description 12.3.5 Teva API Recent Developments 12.4 Divis Laboratories Ltd. 12.4.1 Divis Laboratories Ltd. Corporation Information 12.4.2 Divis Laboratories Ltd. Overview 12.4.3 Divis Laboratories Ltd. Irbesartan API Sales, Price, Revenue and Gross Margin (2016-2021) 12.4.4 Divis Laboratories Ltd. Irbesartan API Product Description 12.4.5 Divis Laboratories Ltd. Recent Developments 12.5 Rundu Pharma 12.5.1 Rundu Pharma Corporation Information 12.5.2 Rundu Pharma Overview 12.5.3 Rundu Pharma Irbesartan API Sales, Price, Revenue and Gross Margin (2016-2021) 12.5.4 Rundu Pharma Irbesartan API Product Description 12.5.5 Rundu Pharma Recent Developments 12.6 Apeloa Pharmaceutical Co., Ltd. 12.6.1 Apeloa Pharmaceutical Co., Ltd. Corporation Information 12.6.2 Apeloa Pharmaceutical Co., Ltd. Overview 12.6.3 Apeloa Pharmaceutical Co., Ltd. Irbesartan API Sales, Price, Revenue and Gross Margin (2016-2021) 12.6.4 Apeloa Pharmaceutical Co., Ltd. Irbesartan API Product Description 12.6.5 Apeloa Pharmaceutical Co., Ltd. Recent Developments 12.7 CTX Lifesciences 12.7.1 CTX Lifesciences Corporation Information 12.7.2 CTX Lifesciences Overview 12.7.3 CTX Lifesciences Irbesartan API Sales, Price, Revenue and Gross Margin (2016-2021) 12.7.4 CTX Lifesciences Irbesartan API Product Description 12.7.5 CTX Lifesciences Recent Developments 12.8 Unichem Laboratories Limited 12.8.1 Unichem Laboratories Limited Corporation Information 12.8.2 Unichem Laboratories Limited Overview 12.8.3 Unichem Laboratories Limited Irbesartan API Sales, Price, Revenue and Gross Margin (2016-2021) 12.8.4 Unichem Laboratories Limited Irbesartan API Product Description 12.8.5 Unichem Laboratories Limited Recent Developments 12.9 Zhejiang Huahai Pharmaceuticals Co., Ltd 12.9.1 Zhejiang Huahai Pharmaceuticals Co., Ltd Corporation Information 12.9.2 Zhejiang Huahai Pharmaceuticals Co., Ltd Overview 12.9.3 Zhejiang Huahai Pharmaceuticals Co., Ltd Irbesartan API Sales, Price, Revenue and Gross Margin (2016-2021) 12.9.4 Zhejiang Huahai Pharmaceuticals Co., Ltd Irbesartan API Product Description 12.9.5 Zhejiang Huahai Pharmaceuticals Co., Ltd Recent Developments 12.10 Smilax Laboratories Limited 12.10.1 Smilax Laboratories Limited Corporation Information 12.10.2 Smilax Laboratories Limited Overview 12.10.3 Smilax Laboratories Limited Irbesartan API Sales, Price, Revenue and Gross Margin (2016-2021) 12.10.4 Smilax Laboratories Limited Irbesartan API Product Description 12.10.5 Smilax Laboratories Limited Recent Developments 13 Industry Chain and Sales Channels Analysis 13.1 Irbesartan API Industry Chain Analysis 13.2 Irbesartan API Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 Irbesartan API Production Mode & Process 13.4 Irbesartan API Sales and Marketing 13.4.1 Irbesartan API Sales Channels 13.4.2 Irbesartan API Distributors 13.5 Irbesartan API Customers 14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 14.1 Irbesartan API Industry Trends 14.2 Irbesartan API Market Drivers 14.3 Irbesartan API Market Challenges 14.4 Irbesartan API Market Restraints 15 Key Finding in The Global Irbesartan API Study 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables
Table 1. Global Irbesartan API Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Purity≥98%
Table 3. Major Manufacturers of Purity<98%
Table 4. Global Irbesartan API Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 5. Global Irbesartan API Production by Region: 2016 VS 2021 VS 2027 (Ton)
Table 6. Global Irbesartan API Production by Region (2016-2021) & (Ton)
Table 7. Global Irbesartan API Production Market Share by Region (2016-2021)
Table 8. Global Irbesartan API Production by Region (2022-2027) & (Ton)
Table 9. Global Irbesartan API Production Market Share by Region (2022-2027)
Table 10. Global Irbesartan API Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 11. Global Irbesartan API Sales by Region (2016-2021) & (Ton)
Table 12. Global Irbesartan API Sales Market Share by Region (2016-2021)
Table 13. Global Irbesartan API Sales by Region (2022-2027) & (Ton)
Table 14. Global Irbesartan API Sales Market Share by Region (2022-2027)
Table 15. Global Irbesartan API Revenue by Region (2016-2021) & (US$ Million)
Table 16. Global Irbesartan API Revenue Market Share by Region (2016-2021)
Table 17. Global Irbesartan API Revenue by Region (2022-2027) & (US$ Million)
Table 18. Global Irbesartan API Revenue Market Share by Region (2022-2027)
Table 19. Global Irbesartan API Production Capacity by Manufacturers (2016-2021) & (Ton)
Table 20. Global Irbesartan API Capacity Market Share by Manufacturers (2016-2021)
Table 21. Global Irbesartan API Production by Manufacturers (2016-2021) & (Ton)
Table 22. Global Irbesartan API Production Market Share by Manufacturers (2016-2021)
Table 23. Global Irbesartan API Sales by Manufacturers (2016-2021) & (Ton)
Table 24. Global Irbesartan API Sales Share by Manufacturers (2016-2021)
Table 25. Global Irbesartan API Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 26. Global Irbesartan API Revenue Share by Manufacturers (2016-2021)
Table 27. Irbesartan API Price by Manufacturers 2016-2021 (US$/Ton)
Table 28. Global Irbesartan API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Irbesartan API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irbesartan API as of 2020)
Table 30. Irbesartan API Manufacturing Base Distribution and Headquarters
Table 31. Manufacturers Irbesartan API Product Offered
Table 32. Date of Manufacturers Enter into Irbesartan API Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Irbesartan API Sales by Type (2016-2021) & (Ton)
Table 35. Global Irbesartan API Sales by Type (2022-2027) & (Ton)
Table 36. Global Irbesartan API Sales Share by Type (2016-2021)
Table 37. Global Irbesartan API Sales Share by Type (2022-2027)
Table 38. Global Irbesartan API Revenue by Type (2016-2021) & (US$ Million)
Table 39. Global Irbesartan API Revenue by Type (2022-2027) & (US$ Million)
Table 40. Global Irbesartan API Revenue Share by Type (2016-2021)
Table 41. Global Irbesartan API Revenue Share by Type (2022-2027)
Table 42. Irbesartan API Price by Type (2016-2021) & (US$/Ton)
Table 43. Global Irbesartan API Price Forecast by Type (2022-2027) & (US$/Ton)
Table 44. Global Irbesartan API Sales by Application (2016-2021) & (Ton)
Table 45. Global Irbesartan API Sales by Application (2022-2027) & (Ton)
Table 46. Global Irbesartan API Sales Share by Application (2016-2021)
Table 47. Global Irbesartan API Sales Share by Application (2022-2027)
Table 48. Global Irbesartan API Revenue by Application (2016-2021) & (US$ Million)
Table 49. Global Irbesartan API Revenue by Application (2022-2027) & (US$ Million)
Table 50. Global Irbesartan API Revenue Share by Application (2016-2021)
Table 51. Global Irbesartan API Revenue Share by Application (2022-2027)
Table 52. Irbesartan API Price by Application (2016-2021) & (US$/Ton)
Table 53. Global Irbesartan API Price Forecast by Application (2022-2027) & (US$/Ton)
Table 54. North America Irbesartan API Sales by Type (2016-2021) & (Ton)
Table 55. North America Irbesartan API Sales by Type (2022-2027) & (Ton)
Table 56. North America Irbesartan API Revenue by Type (2016-2021) & (US$ Million)
Table 57. North America Irbesartan API Revenue by Type (2022-2027) & (US$ Million)
Table 58. North America Irbesartan API Sales by Application (2016-2021) & (Ton)
Table 59. North America Irbesartan API Sales by Application (2022-2027) & (Ton)
Table 60. North America Irbesartan API Revenue by Application (2016-2021) & (US$ Million)
Table 61. North America Irbesartan API Revenue by Application (2022-2027) & (US$ Million)
Table 62. North America Irbesartan API Sales by Country (2016-2021) & (Ton)
Table 63. North America Irbesartan API Sales by Country (2022-2027) & (Ton)
Table 64. North America Irbesartan API Revenue by Country (2016-2021) & (US$ Million)
Table 65. North America Irbesartan API Revenue by Country (2022-2027) & (US$ Million)
Table 66. Europe Irbesartan API Sales by Type (2016-2021) & (Ton)
Table 67. Europe Irbesartan API Sales by Type (2022-2027) & (Ton)
Table 68. Europe Irbesartan API Revenue by Type (2016-2021) & (US$ Million)
Table 69. Europe Irbesartan API Revenue by Type (2022-2027) & (US$ Million)
Table 70. Europe Irbesartan API Sales by Application (2016-2021) & (Ton)
Table 71. Europe Irbesartan API Sales by Application (2022-2027) & (Ton)
Table 72. Europe Irbesartan API Revenue by Application (2016-2021) & (US$ Million)
Table 73. Europe Irbesartan API Revenue by Application (2022-2027) & (US$ Million)
Table 74. Europe Irbesartan API Sales by Country (2016-2021) & (Ton)
Table 75. Europe Irbesartan API Sales by Country (2022-2027) & (Ton)
Table 76. Europe Irbesartan API Revenue by Country (2016-2021) & (US$ Million)
Table 77. Europe Irbesartan API Revenue by Country (2022-2027) & (US$ Million)
Table 78. Asia Pacific Irbesartan API Sales by Type (2016-2021) & (Ton)
Table 79. Asia Pacific Irbesartan API Sales by Type (2022-2027) & (Ton)
Table 80. Asia Pacific Irbesartan API Revenue by Type (2016-2021) & (US$ Million)
Table 81. Asia Pacific Irbesartan API Revenue by Type (2022-2027) & (US$ Million)
Table 82. Asia Pacific Irbesartan API Sales by Application (2016-2021) & (Ton)
Table 83. Asia Pacific Irbesartan API Sales by Application (2022-2027) & (Ton)
Table 84. Asia Pacific Irbesartan API Revenue by Application (2016-2021) & (US$ Million)
Table 85. Asia Pacific Irbesartan API Revenue by Application (2022-2027) & (US$ Million)
Table 86. Asia Pacific Irbesartan API Sales by Region (2016-2021) & (Ton)
Table 87. Asia Pacific Irbesartan API Sales by Region (2022-2027) & (Ton)
Table 88. Asia Pacific Irbesartan API Revenue by Region (2016-2021) & (US$ Million)
Table 89. Asia Pacific Irbesartan API Revenue by Region (2022-2027) & (US$ Million)
Table 90. Latin America Irbesartan API Sales by Type (2016-2021) & (Ton)
Table 91. Latin America Irbesartan API Sales by Type (2022-2027) & (Ton)
Table 92. Latin America Irbesartan API Revenue by Type (2016-2021) & (US$ Million)
Table 93. Latin America Irbesartan API Revenue by Type (2022-2027) & (US$ Million)
Table 94. Latin America Irbesartan API Sales by Application (2016-2021) & (Ton)
Table 95. Latin America Irbesartan API Sales by Application (2022-2027) & (Ton)
Table 96. Latin America Irbesartan API Revenue by Application (2016-2021) & (US$ Million)
Table 97. Latin America Irbesartan API Revenue by Application (2022-2027) & (US$ Million)
Table 98. Latin America Irbesartan API Sales by Country (2016-2021) & (Ton)
Table 99. Latin America Irbesartan API Sales by Country (2022-2027) & (Ton)
Table 100. Latin America Irbesartan API Revenue by Country (2016-2021) & (US$ Million)
Table 101. Latin America Irbesartan API Revenue by Country (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Irbesartan API Sales by Type (2016-2021) & (Ton)
Table 103. Middle East and Africa Irbesartan API Sales by Type (2022-2027) & (Ton)
Table 104. Middle East and Africa Irbesartan API Revenue by Type (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Irbesartan API Revenue by Type (2022-2027) & (US$ Million)
Table 106. Middle East and Africa Irbesartan API Sales by Application (2016-2021) & (Ton)
Table 107. Middle East and Africa Irbesartan API Sales by Application (2022-2027) & (Ton)
Table 108. Middle East and Africa Irbesartan API Revenue by Application (2016-2021) & (US$ Million)
Table 109. Middle East and Africa Irbesartan API Revenue by Application (2022-2027) & (US$ Million)
Table 110. Middle East and Africa Irbesartan API Sales by Country (2016-2021) & (Ton)
Table 111. Middle East and Africa Irbesartan API Sales by Country (2022-2027) & (Ton)
Table 112. Middle East and Africa Irbesartan API Revenue by Country (2016-2021) & (US$ Million)
Table 113. Middle East and Africa Irbesartan API Revenue by Country (2022-2027) & (US$ Million)
Table 114. Dr. Reddy’s Laboratories Ltd. Corporation Information
Table 115. Dr. Reddy’s Laboratories Ltd. Description and Major Businesses
Table 116. Dr. Reddy’s Laboratories Ltd. Irbesartan API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 117. Dr. Reddy’s Laboratories Ltd. Irbesartan API Product
Table 118. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 119. Tecoland Corporation Corporation Information
Table 120. Tecoland Corporation Description and Major Businesses
Table 121. Tecoland Corporation Irbesartan API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 122. Tecoland Corporation Irbesartan API Product
Table 123. Tecoland Corporation Recent Development
Table 124. Teva API Corporation Information
Table 125. Teva API Description and Major Businesses
Table 126. Teva API Irbesartan API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 127. Teva API Irbesartan API Product
Table 128. Teva API Recent Development
Table 129. Divis Laboratories Ltd. Corporation Information
Table 130. Divis Laboratories Ltd. Description and Major Businesses
Table 131. Divis Laboratories Ltd. Irbesartan API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 132. Divis Laboratories Ltd. Irbesartan API Product
Table 133. Divis Laboratories Ltd. Recent Development
Table 134. Rundu Pharma Corporation Information
Table 135. Rundu Pharma Description and Major Businesses
Table 136. Rundu Pharma Irbesartan API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 137. Rundu Pharma Irbesartan API Product
Table 138. Rundu Pharma Recent Development
Table 139. Apeloa Pharmaceutical Co., Ltd. Corporation Information
Table 140. Apeloa Pharmaceutical Co., Ltd. Description and Major Businesses
Table 141. Apeloa Pharmaceutical Co., Ltd. Irbesartan API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 142. Apeloa Pharmaceutical Co., Ltd. Irbesartan API Product
Table 143. Apeloa Pharmaceutical Co., Ltd. Recent Development
Table 144. CTX Lifesciences Corporation Information
Table 145. CTX Lifesciences Description and Major Businesses
Table 146. CTX Lifesciences Irbesartan API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 147. CTX Lifesciences Irbesartan API Product
Table 148. CTX Lifesciences Recent Development
Table 149. Unichem Laboratories Limited Corporation Information
Table 150. Unichem Laboratories Limited Description and Major Businesses
Table 151. Unichem Laboratories Limited Irbesartan API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 152. Unichem Laboratories Limited Irbesartan API Product
Table 153. Unichem Laboratories Limited Recent Development
Table 154. Zhejiang Huahai Pharmaceuticals Co., Ltd Corporation Information
Table 155. Zhejiang Huahai Pharmaceuticals Co., Ltd Description and Major Businesses
Table 156. Zhejiang Huahai Pharmaceuticals Co., Ltd Irbesartan API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 157. Zhejiang Huahai Pharmaceuticals Co., Ltd Irbesartan API Product
Table 158. Zhejiang Huahai Pharmaceuticals Co., Ltd Recent Development
Table 159. Smilax Laboratories Limited Corporation Information
Table 160. Smilax Laboratories Limited Description and Major Businesses
Table 161. Smilax Laboratories Limited Irbesartan API Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 162. Smilax Laboratories Limited Irbesartan API Product
Table 163. Smilax Laboratories Limited Recent Development
Table 164. Key Raw Materials Lists
Table 165. Raw Materials Key Suppliers Lists
Table 166. Irbesartan API Distributors List
Table 167. Irbesartan API Customers List
Table 168. Irbesartan API Market Trends
Table 169. Irbesartan API Market Drivers
Table 170. Irbesartan API Market Challenges
Table 171. Irbesartan API Market Restraints
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Irbesartan API Product Picture
Figure 2. Global Irbesartan API Market Share by Type in 2020 & 2027
Figure 3. Purity≥98% Product Picture
Figure 4. Purity<98% Product Picture
Figure 5. Global Irbesartan API Market Share by Application in 2020 & 2027
Figure 6. Irbesartan Tablets
Figure 7. Others
Figure 8. Irbesartan API Report Years Considered
Figure 9. Global Irbesartan API Capacity, Production and Utilization (2016-2027) & (Ton)
Figure 10. Global Irbesartan API Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 11. Global Irbesartan API Production Market Share by Region (2016-2021)
Figure 12. Global Irbesartan API Production Market Share by Region (2022-2027)
Figure 13. Irbesartan API Production Growth Rate in North America (2016-2027) & (Ton)
Figure 14. Irbesartan API Production Growth Rate in India (2016-2027) & (Ton)
Figure 15. Irbesartan API Production Growth Rate in China (2016-2027) & (Ton)
Figure 16. Irbesartan API Production Growth Rate in Israel (2016-2027) & (Ton)
Figure 17. Global Irbesartan API Sales 2016-2027 (Ton)
Figure 18. Global Irbesartan API Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Irbesartan API Revenue 2016-2027 (US$ Million)
Figure 20. Global Irbesartan API Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 21. Global Irbesartan API Sales Market Share by Region (2016-2021)
Figure 22. Global Irbesartan API Sales Market Share by Region (2022-2027)
Figure 23. North America Irbesartan API Sales YoY (2016-2027) & (Ton)
Figure 24. North America Irbesartan API Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Europe Irbesartan API Sales YoY (2016-2027) & (Ton)
Figure 26. Europe Irbesartan API Revenue YoY (2016-2027) & (US$ Million)
Figure 27. Asia-Pacific Irbesartan API Sales YoY (2016-2027) & (Ton)
Figure 28. Asia-Pacific Irbesartan API Revenue YoY (2016-2027) & (US$ Million)
Figure 29. Latin America Irbesartan API Sales YoY (2016-2027) & (Ton)
Figure 30. Latin America Irbesartan API Revenue YoY (2016-2027) & (US$ Million)
Figure 31. Middle East & Africa Irbesartan API Sales YoY (2016-2027) & (Ton)
Figure 32. Middle East & Africa Irbesartan API Revenue YoY (2016-2027) & (US$ Million)
Figure 33. The Top 10 and Top 5 Players Market Share by Irbesartan API Sales in 2020
Figure 34. The Top 10 and Top 5 Players Market Share by Irbesartan API Revenue in 2020
Figure 35. Irbesartan API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 36. Global Irbesartan API Sales Market Share by Type (2016-2027)
Figure 37. Global Irbesartan API Revenue Market Share by Type (2016-2027)
Figure 38. Global Irbesartan API Sales Market Share by Application (2016-2027)
Figure 39. Global Irbesartan API Revenue Market Share by Application (2016-2027)
Figure 40. North America Irbesartan API Sales Market Share by Type (2016-2027)
Figure 41. North America Irbesartan API Revenue Market Share by Type (2016-2027)
Figure 42. North America Irbesartan API Sales Market Share by Application (2016-2027)
Figure 43. North America Irbesartan API Revenue Market Share by Application (2016-2027)
Figure 44. North America Irbesartan API Sales Share by Country (2016-2027)
Figure 45. North America Irbesartan API Revenue Share by Country (2016-2027)
Figure 46. United States Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 47. Canada Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 48. Europe Irbesartan API Sales Market Share by Type (2016-2027)
Figure 49. Europe Irbesartan API Revenue Market Share by Type (2016-2027)
Figure 50. Europe Irbesartan API Sales Market Share by Application (2016-2027)
Figure 51. Europe Irbesartan API Revenue Market Share by Application (2016-2027)
Figure 52. Europe Irbesartan API Sales Share by Country (2016-2027)
Figure 53. Europe Irbesartan API Revenue Share by Country (2016-2027)
Figure 54. Germany Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 55. France Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 56. U.K. Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 57. Italy Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 58. Russia Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 59. Asia Pacific Irbesartan API Sales Market Share by Type (2016-2027)
Figure 60. Asia Pacific Irbesartan API Revenue Market Share by Type (2016-2027)
Figure 61. Asia Pacific Irbesartan API Sales Market Share by Application (2016-2027)
Figure 62. Asia Pacific Irbesartan API Revenue Market Share by Application (2016-2027)
Figure 63. Asia Pacific Irbesartan API Sales Share by Region (2016-2027)
Figure 64. Asia Pacific Irbesartan API Revenue Share by Region (2016-2027)
Figure 65. China Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 66. Japan Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 67. South Korea Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 68. India Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 69. Australia Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 70. China Taiwan Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 71. Indonesia Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 72. Thailand Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 73. Malaysia Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 74. Latin America Irbesartan API Sales Market Share by Type (2016-2027)
Figure 75. Latin America Irbesartan API Revenue Market Share by Type (2016-2027)
Figure 76. Latin America Irbesartan API Sales Market Share by Application (2016-2027)
Figure 77. Latin America Irbesartan API Revenue Market Share by Application (2016-2027)
Figure 78. Latin America Irbesartan API Sales Share by Country (2016-2027)
Figure 79. Latin America Irbesartan API Revenue Share by Country (2016-2027)
Figure 80. Mexico Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 81. Brazil Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 82. Argentina Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 83. Middle East and Africa Irbesartan API Sales Market Share by Type (2016-2027)
Figure 84. Middle East and Africa Irbesartan API Revenue Market Share by Type (2016-2027)
Figure 85. Middle East and Africa Irbesartan API Sales Market Share by Application (2016-2027)
Figure 86. Middle East and Africa Irbesartan API Revenue Market Share by Application (2016-2027)
Figure 87. Middle East and Africa Irbesartan API Sales Share by Country (2016-2027)
Figure 88. Middle East and Africa Irbesartan API Revenue Share by Country (2016-2027)
Figure 89. Turkey Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 90. Saudi Arabia Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 91. UAE Irbesartan API Revenue (2016-2027) & (US$ Million)
Figure 92. Irbesartan API Value Chain
Figure 93. Irbesartan API Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed

---